Albert Labs International Corp. Share Price OTC Markets
Equities
ALBLF
CA0127841041
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
Sales 2021 | - | Sales 2022 | - | Capitalization | 27.27L 23Cr |
---|---|---|---|---|---|
Net income 2021 | -10L -8.35Cr | Net income 2022 | -70L -58Cr | EV / Sales 2021 * | - |
Net cash position 2021 | 76.7T 64.05L | Net cash position 2022 | 79.12T 66.07L | EV / Sales 2022 | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-0.32
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 84.71% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Robert Kang
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | 61 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Navchand Jagpal
COO | Chief Operating Officer | - | - |
Ravinder Kang
BRD | Director/Board Member | 58 | - |
1st Jan change | Capi. | |
---|---|---|
+46.19% | 5.67TCr | |
-6.14% | 3.94TCr | |
+39.19% | 3.9TCr | |
-6.65% | 2.69TCr | |
+12.33% | 2.67TCr | |
-21.78% | 1.9TCr | |
-0.35% | 1.23TCr | |
+24.18% | 1.23TCr | |
+28.38% | 1.2TCr |
- Stock Market
- Equities
- ABRT Stock
- ALBLF Stock